Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review

Gallbladder carcinoma (GBC) is a relatively rare and aggressive malignant tumor with a poor prognosis. A systematic review of current clinical studies illustrates an extreme paucity of second-line therapeutic options following the failure of standard-of-care cisplatin-gemcitabine chemotherapy. The e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengxi, Zhang, Pengfei, Zhou, Kexun, Li, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856073/
https://www.ncbi.nlm.nih.gov/pubmed/31788447
http://dx.doi.org/10.3389/fonc.2019.01180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856073/
https://www.ncbi.nlm.nih.gov/pubmed/31788447
http://dx.doi.org/10.3389/fonc.2019.01180

Ejemplares similares